Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan
Crossref DOI link: https://doi.org/10.1007/s12325-020-01396-w
Published Online: 2020-06-04
Published Print: 2020-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Iwata, Nakao
Inagaki, Ataru
Sano, Hiromi
Niidome, Kazunari
Kojima, Yoshitsugu
Yamada, Sakiko
Funding for this research was provided by:
Otsuka Pharmaceutical
Text and Data Mining valid from 2020-06-04
Version of Record valid from 2020-06-04
Article History
Received: 27 February 2020
First Online: 4 June 2020